Literature DB >> 33722217

Joint association of cigarette smoking and PM2.5 with COPD among urban and rural adults in regional China.

Jian Su1, Qing Ye2, Dandan Zhang3,4, Fei Xu5, Jinyi Zhou1, Ran Tao1, Zhen Ding6, Gan Lu3, Jiannan Liu7.   

Abstract

BACKGROUND: Cigarette smoking and PM2.5 are important risk factors of Chronic Obstructive Pulmonary Disease (COPD). However, the joint association of cigarette smoking and PM2.5 with COPD is unknown.
METHODS: A community-based study was conducted among urban and rural adults aged 40 + years between May and December of 2015 in Jiangsu Province, China. The outcome variable was spirometry-defined COPD. Explanatory measures were smoking status (non-smokers or smokers) and PM2.5 exposure [low level (< 75 μg/m3) or high level (≥ 75 μg/m3)]. Mixed-effects logistic regression models were applied to calculate the odds ratio (OR) and 95% confidence interval (CI) to investigate the associations of cigarette smoking and PM2.5 with COPD.
RESULTS: The prevalence of COPD was 11.9% (95% CI = 10.9%, 13.0%) within the overall 3407 participants in this study. After adjustment for potential confounders and community-level clustering effect, smokers tended to develop COPD relative to non-smokers (OR = 2.46, 95% CI 1.76, 3.43), while only smokers exposed to high level PM2.5 were more likely to experience COPD (OR = 1.36; 95% CI 1.01, 1.83) compared to their counterparts exposed to low level PM2.5. Meanwhile, compared to non-smokers who exposed to low level PM2.5, non-smokers who exposed to high level PM2.5 (OR = 1.10, 95% CI 0.74, 1.64), smokers who exposed to low (OR = 2.22, 95% CI 1.51, 3.27) or high level PM2.5 (OR = 3.14, 95% CI 2.15, 4.59) were, respectively, more like to develop COPD.
CONCLUSIONS: Cigarette smoking was positively associated with COPD among overall participants, while PM2.5 was in positive relation to COPD among smokers only. Moreover, cigarette smoking and PM2.5 might have an additive effect on the risk of COPD among adult smokers aged 40 years or older in China.

Entities:  

Keywords:  Adults; COPD; Cigarette smoking; PM2.5

Year:  2021        PMID: 33722217      PMCID: PMC7962238          DOI: 10.1186/s12890-021-01465-y

Source DB:  PubMed          Journal:  BMC Pulm Med        ISSN: 1471-2466            Impact factor:   3.317


  24 in total

1.  Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study.

Authors:  Chen Wang; Jianying Xu; Lan Yang; Yongjian Xu; Xiangyan Zhang; Chunxue Bai; Jian Kang; Pixin Ran; Huahao Shen; Fuqiang Wen; Kewu Huang; Wanzhen Yao; Tieying Sun; Guangliang Shan; Ting Yang; Yingxiang Lin; Sinan Wu; Jianguo Zhu; Ruiying Wang; Zhihong Shi; Jianping Zhao; Xianwei Ye; Yuanlin Song; Qiuyue Wang; Yumin Zhou; Liren Ding; Ting Yang; Yahong Chen; Yanfei Guo; Fei Xiao; Yong Lu; Xiaoxia Peng; Biao Zhang; Dan Xiao; Chung-Shiuan Chen; Zuomin Wang; Hong Zhang; Xiaoning Bu; Xiaolei Zhang; Li An; Shu Zhang; Zhixin Cao; Qingyuan Zhan; Yuanhua Yang; Bin Cao; Huaping Dai; Lirong Liang; Jiang He
Journal:  Lancet       Date:  2018-04-09       Impact factor: 79.321

2.  Long-term exposure to traffic emissions and fine particulate matter and lung function decline in the Framingham heart study.

Authors:  Mary B Rice; Petter L Ljungman; Elissa H Wilker; Kirsten S Dorans; Diane R Gold; Joel Schwartz; Petros Koutrakis; George R Washko; George T O'Connor; Murray A Mittleman
Journal:  Am J Respir Crit Care Med       Date:  2015-03-15       Impact factor: 21.405

Review 3.  Systematic review with meta-analysis of the epidemiological evidence relating smoking to COPD, chronic bronchitis and emphysema.

Authors:  Barbara A Forey; Alison J Thornton; Peter N Lee
Journal:  BMC Pulm Med       Date:  2011-06-14       Impact factor: 3.317

Review 4.  Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019.

Authors:  Dave Singh; Alvar Agusti; Antonio Anzueto; Peter J Barnes; Jean Bourbeau; Bartolome R Celli; Gerard J Criner; Peter Frith; David M G Halpin; Meilan Han; M Victorina López Varela; Fernando Martinez; Maria Montes de Oca; Alberto Papi; Ian D Pavord; Nicolas Roche; Donald D Sin; Robert Stockley; Jørgen Vestbo; Jadwiga A Wedzicha; Claus Vogelmeier
Journal:  Eur Respir J       Date:  2019-05-18       Impact factor: 16.671

5.  Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey.

Authors:  Nanshan Zhong; Chen Wang; Wanzhen Yao; Ping Chen; Jian Kang; Shaoguang Huang; Baoyuan Chen; Changzheng Wang; Diantao Ni; Yumin Zhou; Shengming Liu; Xiaoping Wang; Dali Wang; Jiachun Lu; Jingping Zheng; Pixin Ran
Journal:  Am J Respir Crit Care Med       Date:  2007-06-15       Impact factor: 21.405

6.  Better understanding the influence of cigarette smoking and indoor air pollution on chronic obstructive pulmonary disease: a case-control study in Mainland China.

Authors:  Fei Xu; XiaoMei Yin; HongBing Shen; YaoChu Xu; Robert S Ware; Neville Owen
Journal:  Respirology       Date:  2007-11       Impact factor: 6.424

7.  Chronic obstructive pulmonary disease in China: a nationwide prevalence study.

Authors:  Liwen Fang; Pei Gao; Heling Bao; Xun Tang; Baohua Wang; Yajing Feng; Shu Cong; Juan Juan; Jing Fan; Ke Lu; Ning Wang; Yonghua Hu; Linhong Wang
Journal:  Lancet Respir Med       Date:  2018-04-09       Impact factor: 30.700

Review 8.  Global and regional estimates of COPD prevalence: Systematic review and meta-analysis.

Authors:  Davies Adeloye; Stephen Chua; Chinwei Lee; Catriona Basquill; Angeliki Papana; Evropi Theodoratou; Harish Nair; Danijela Gasevic; Devi Sridhar; Harry Campbell; Kit Yee Chan; Aziz Sheikh; Igor Rudan
Journal:  J Glob Health       Date:  2015-12       Impact factor: 7.664

9.  An integrated national mortality surveillance system for death registration and mortality surveillance, China.

Authors:  Shiwei Liu; Xiaoling Wu; Alan D Lopez; Lijun Wang; Yue Cai; Andrew Page; Peng Yin; Yunning Liu; Yichong Li; Jiangmei Liu; Jinling You; Maigeng Zhou
Journal:  Bull World Health Organ       Date:  2015-10-28       Impact factor: 9.408

10.  PM2.5 Spatiotemporal Variations and the Relationship with Meteorological Factors during 2013-2014 in Beijing, China.

Authors:  Fangfang Huang; Xia Li; Chao Wang; Qin Xu; Wei Wang; Yanxia Luo; Lixin Tao; Qi Gao; Jin Guo; Sipeng Chen; Kai Cao; Long Liu; Ni Gao; Xiangtong Liu; Kun Yang; Aoshuang Yan; Xiuhua Guo
Journal:  PLoS One       Date:  2015-11-03       Impact factor: 3.240

View more
  3 in total

Review 1.  Particulate matter in COPD pathogenesis: an overview.

Authors:  Manpreet Kaur; Jitender Chandel; Jai Malik; Amarjit S Naura
Journal:  Inflamm Res       Date:  2022-06-16       Impact factor: 6.986

2.  Exploring influencing factors of chronic obstructive pulmonary disease based on elastic net and Bayesian network.

Authors:  Dichen Quan; Jiahui Ren; Hao Ren; Liqin Linghu; Xuchun Wang; Meichen Li; Yuchao Qiao; Zeping Ren; Lixia Qiu
Journal:  Sci Rep       Date:  2022-05-09       Impact factor: 4.996

3.  Analysis of the association of ANO3/MUC15, COL4A4, RRBP1, and KLK1 polymorphisms with COPD susceptibility in the Kashi population.

Authors:  Lifeng Tang; Xuemei Zhong; Hui Gong; Maimaitiaili Tuerxun; Tao Ma; Jie Ren; Chengxin Xie; Aifang Zheng; Zulipikaer Abudureheman; Ayiguzali Abudukadeer; Paierda Aini; Subinuer Yilamujiang; Li Li
Journal:  BMC Pulm Med       Date:  2022-05-05       Impact factor: 3.320

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.